Evaluation of the gamma probe guided sentinel lymph node biopsy and the blue dye technique in the management of breast cancer

Hellenic Journal of Nuclear Medicine

Volumn 13, Issue 1, 2010, Pages 30-34

  Usmani, Sharjeel ^a   Khan, Haider Ali ^a   Huda, Fawazabu ^a   Ahmed, Najeeb ^a   Al Nafisi, Naheel ^a   Marafi, Fahad ^a   Al Mohannadi, Shihab ^a   Javed, Amir ^a   Amanguno, Henney G ^a   Al Saleh, Noha ^a  

^a Hussain Makki Al Jumma Centre for Specialized Surgery   (Kuwait)

Author keywords

99mTc nanocolloid; Breast carcinoma; Lymphoscintigraphy; Sentinel lymph node; The dye technique

Indexed keywords

ISOSULFAN BLUE; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; CLINICAL EVALUATION; COLLOID; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GAMMA RADIATION; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; COLORING AGENTS; FEMALE; HUMANS; MIDDLE AGED; RADIONUCLIDE IMAGING; REPRODUCIBILITY OF RESULTS; ROSANILINE DYES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SURGERY, COMPUTER-ASSISTED; YOUNG ADULT;

EID: 77951826027     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Schwartz GF, Veronesi U, Clough KB et al. Consensus Conference Committee. Consensus conference on breast conservation, Milan, Italy, April 28-May 1,2005. Breast J 2006;12:398-407.
2. Lyman GH, Giuliano AE, Somerfield MR et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-7720.
3. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 2006,106:4-16. (Pubitemid 43033320)
4. Veronesi U, Paganelli G, Viale G et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006;7:983-990. (Pubitemid 44804136)
5. Veronesi U, Paganelli G, Viale G et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-553. (Pubitemid 36951366)
6. Rodier JF, Veiten M, Wilt M et al. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial. J Clin Oncol 2007; 25(24):3664-3669. (Pubitemid 47372605)
7. Canavese G, Catturich A, Vecchio C et al. Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial. Ann Oncol 2009;20:1001-1007.
8. Veronesi U, Galimberti V, Mariani L et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 2005;41:231-237. (Pubitemid 40126955)
9. Zavagno G, De Salvo GL, Scalco G et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008;247:207-213. (Pubitemid 351156760)
10. Vijayakumar V, Boerner PS, Jani AB. A critical review of variables affecting the accuracy and false-negative rate of sentinel node biopsy procedures in early breast cancer. Nucl Med Commun 2005;26:395-405. (Pubitemid 40617727)
11. Aarsvold JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med 2005;35:116-128.
12. Ozmen V, Unal ES, Muslumanoglu ME et al. Axillary sentinel node biopsy after neoadjuvant chemotherapy. Eur J Surg Oncol 2010;36:23-29.
13. Chakera AH, Friis E, Hesse U et al. Factors of importance for scintigraphaphic non-visualization of sentinel nodes in breast cancer. Eur J Nucl Med Mol Imaging 2005;32:286-293. (Pubitemid 40562119)
14. Cody HS. Clinical aspects of sentinel lymph node biopsy. Breast Cancer Res 2001;3:104-108. (Pubitemid 32273123)
15. Albertini JJ, Lyman GH, Cox C et al. Lymphatic mapping and sentinel biopsy in the patient with breast cancer. JAMA 1996;276:1818-1822. (Pubitemid 26406231)
16. Takei H, Kurosumi M, Yoshida T et al. Current trends of sentinel lymph node biopsy for breast cancer-a surgeon's perspective. Breast Cancer 2007;14:362-370.
17. Derossis AM, Fey J, Yeung H et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001;193:473-478.
18. Sanli I, Lemaire BM, Muller AJ et al. Axillary recurrence after negative sentinel lymph node biopsy: frequency and factors influencing recurrence on the long term. Breast 2009;15:236-241.
19. Swenson KK, Mahipal A, Nissen MJ et al. Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma. Cancer 2005;104:1834-1839. (Pubitemid 41513165)
20. Edge SB, Niland JC, Bookman MA et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst 2003;95:1514-1521.
21. Fisher B, Jong-Hyeon J, Anderson S et al. Twenty-five year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002;347:567-575.
22. Heuts EM, van der Ent FW, Hulsewé KW et al. Incidence of axillary recurrence in 344 sentinel node negative breast cancer patients after intermediate follow-up. A prospective study into the accuracy of sentinel node biopsy in breast cancer patients. Acta Chir Belg 2007;107:279-283.
23. Poletti P, Fenaroli P, Milesi A et al. Axillary recurrence in sentinel lymph node-negative breast cancer patients. Ann Oncol 2008;19:1842-1846.
24. Langer I, Marti WR, Guller U et al. A. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases. Ann Surg 2005;241:152-158.